Details of the Drug Combination

General Information of Drug Combination (ID: DCVRUH8)

Drug Combination Name
MG-132 Idarubicin
Indication
Disease Entry Status REF
Glioblastoma? Investigative [1]
Component Drugs MG-132   DMKA2YS Idarubicin   DMM0XGL
N.A. Small molecular drug
2D MOL 2D MOL
3D MOL 3D MOL
High-throughput Screening Result Testing Cell Line: T98G
Zero Interaction Potency (ZIP) Score: 0.31
Bliss Independence Score: 0.31
Loewe Additivity Score: 0.36
LHighest Single Agent (HSA) Score: 0.45

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
MG-132 Interacts with 1 DTP Molecule(s)
DTP Name DTP ID UniProt ID Mode of Action REF
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [12]
------------------------------------------------------------------------------------
MG-132 Interacts with 183 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Carbonyl reductase 3 (CBR3) OT9G6SF0 CBR3_HUMAN Increases Expression [13]
Glutathione S-transferase A2 (GSTA2) OTW7UB1H GSTA2_HUMAN Increases Expression [14]
Actin, cytoplasmic 1 (ACTB) OT1MCP2F ACTB_HUMAN Decreases Expression [15]
Peptidyl-prolyl cis-trans isomerase A (PPIA) OTHJMWQQ PPIA_HUMAN Decreases Expression [15]
Glutathione S-transferase P (GSTP1) OTLP0A0Y GSTP1_HUMAN Increases Expression [16]
Endothelin-1 (EDN1) OTZCACEG EDN1_HUMAN Increases Expression [4]
Prostaglandin G/H synthase 2 (PTGS2) OT75U9M4 PGH2_HUMAN Increases Expression [4]
Nitric oxide synthase 3 (NOS3) OTLDT7NR NOS3_HUMAN Decreases Degradation [17]
Aldo-keto reductase family 1 member B10 (AKR1B10) OTOA4HTH AK1BA_HUMAN Increases Expression [18]
Aldo-keto reductase family 1 member B1 (AKR1B1) OTRX72TH ALDR_HUMAN Increases Expression [18]
Aldo-keto reductase family 1 member C3 (AKR1C3) OTU2SXBA AK1C3_HUMAN Increases Expression [18]
Aldo-keto reductase family 1 member C1 (AKR1C1) OTQKR4CM AK1C1_HUMAN Increases Expression [18]
Eukaryotic translation initiation factor 2 subunit 1 (EIF2S1) OTM0GDTP IF2A_HUMAN Increases Expression [19]
Nuclear receptor subfamily 1 group I member 3 (NR1I3) OTS3SGH7 NR1I3_HUMAN Decreases Activity [20]
Transcription factor Sp3 (SP3) OTYDQZ1T SP3_HUMAN Increases Expression [21]
HCLS1-associated protein X-1 (HAX1) OTOJWV3F HAX1_HUMAN Affects Expression [22]
Tumor necrosis factor receptor superfamily member 10A (TNFRSF10A) OTBPCU2O TR10A_HUMAN Increases Expression [9]
26S proteasome non-ATPase regulatory subunit 11 (PSMD11) OT8KO67V PSD11_HUMAN Increases Expression [23]
26S proteasome non-ATPase regulatory subunit 12 (PSMD12) OTWICA51 PSD12_HUMAN Increases Expression [23]
26S proteasome non-ATPase regulatory subunit 14 (PSMD14) OTJWHMZ5 PSDE_HUMAN Increases Expression [23]
Suppressor of cytokine signaling 3 (SOCS3) OTY183WJ SOCS3_HUMAN Decreases Degradation [24]
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) OTA1CPBV TR10B_HUMAN Increases Expression [9]
Proteasome subunit alpha type-7 (PSMA7) OTPHI6ST PSA7_HUMAN Increases Expression [23]
Transcription regulator protein BACH1 (BACH1) OTY8004K BACH1_HUMAN Increases Expression [25]
Inhibitor of nuclear factor kappa-B kinase subunit alpha (CHUK) OTLF4ZB1 IKKA_HUMAN Increases Activity [26]
Baculoviral IAP repeat-containing protein 5 (BIRC5) OTILXZYL BIRC5_HUMAN Increases Expression [27]
CASP8 and FADD-like apoptosis regulator (CFLAR) OTX14BAS CFLAR_HUMAN Affects Expression [28]
Cytochrome P450 26A1 (CYP26A1) OTL1DFWV CP26A_HUMAN Decreases Expression [23]
26S proteasome non-ATPase regulatory subunit 3 (PSMD3) OT585WY8 PSMD3_HUMAN Increases Expression [23]
Serine protease HTRA2, mitochondrial (HTRA2) OTC7616F HTRA2_HUMAN Increases Expression [22]
E3 ubiquitin-protein ligase parkin (PRKN) OTJBN41W PRKN_HUMAN Decreases Expression [29]
E3 ubiquitin-protein ligase MARCHF6 (MARCHF6) OTBTA03N MARH6_HUMAN Increases Stability [30]
Nuclear protein 1 (NUPR1) OT4FU8C0 NUPR1_HUMAN Increases Expression [23]
Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 (PLOD3) OTT00T7Q PLOD3_HUMAN Decreases Expression [31]
Microphthalmia-associated transcription factor (MITF) OT6XJCZH MITF_HUMAN Decreases Expression [23]
Serine/threonine-protein kinase/endoribonuclease IRE1 (ERN1) OTY9R6FZ ERN1_HUMAN Increases Expression [32]
Protein phosphatase 1 regulatory subunit 15A (PPP1R15A) OTYG179K PR15A_HUMAN Increases Expression [33]
Pre-mRNA-splicing factor SPF27 (BCAS2) OTRMF2WY SPF27_HUMAN Decreases Expression [23]
Glutathione reductase, mitochondrial (GSR) OTM2TUYM GSHR_HUMAN Increases Expression [25]
Superoxide dismutase (SOD1) OT39TA1L SODC_HUMAN Decreases Expression [34]
Epidermal growth factor receptor (EGFR) OTAPLO1S EGFR_HUMAN Decreases Expression [35]
Myc proto-oncogene protein (MYC) OTPV5LUK MYC_HUMAN Increases Expression [36]
GTPase KRas (KRAS) OT78QCN8 RASK_HUMAN Increases Expression [23]
Pro-epidermal growth factor (EGF) OTANRJ0L EGF_HUMAN Increases Expression [23]
Insulin-like growth factor II (IGF2) OTJ4O6MW IGF2_HUMAN Decreases Response To Substance [37]
Tumor necrosis factor (TNF) OT4IE164 TNFA_HUMAN Decreases Expression [23]
Interleukin-1 beta (IL1B) OT0DWXXB IL1B_HUMAN Decreases Response To Substance [38]
Fibronectin (FN1) OTB5ZN4Q FINC_HUMAN Decreases Secretion [39]
Estrogen receptor (ESR1) OTKLU61J ESR1_HUMAN Decreases Expression [23]
Glucocorticoid receptor (NR3C1) OTCI2YDI GCR_HUMAN Increases Expression [23]
Receptor tyrosine-protein kinase erbB-2 (ERBB2) OTOAUNCK ERBB2_HUMAN Decreases Expression [23]
Cellular tumor antigen p53 (TP53) OTIE1VH3 P53_HUMAN Increases Expression [23]
Interleukin-6 (IL6) OTUOSCCU IL6_HUMAN Increases Expression [40]
Progesterone receptor (PGR) OT0FZ3QE PRGR_HUMAN Increases Expression [41]
Glutathione peroxidase 1 (GPX1) OTE2O72Q GPX1_HUMAN Increases Expression [34]
Cathepsin D (CTSD) OTQZ36F3 CATD_HUMAN Increases Cleavage [7]
Annexin A2 (ANXA2) OTFNS0CC ANXA2_HUMAN Decreases Expression [23]
Steryl-sulfatase (STS) OTXTJQPC STS_HUMAN Decreases Expression [37]
Heme oxygenase 1 (HMOX1) OTC1W6UX HMOX1_HUMAN Increases Expression [6]
Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) OTIRPN6B ROA1_HUMAN Increases Expression [42]
Poly polymerase 1 (PARP1) OT310QSG PARP1_HUMAN Increases Cleavage [43]
Interleukin-8 (CXCL8) OTS7T5VH IL8_HUMAN Increases Expression [44]
Retinoic acid receptor alpha (RARA) OT192V9V RARA_HUMAN Increases Ubiquitination [45]
Retinol-binding protein 3 (RBP3) OTIWM4GT RET3_HUMAN Decreases Degradation [46]
Endoplasmic reticulum chaperone BiP (HSPA5) OTFUIRAO BIP_HUMAN Increases Expression [32]
Solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1) OTA675TJ GTR1_HUMAN Increases Expression [47]
Steroid hormone receptor ERR1 (ESRRA) OTTDTUSP ERR1_HUMAN Increases Expression [48]
NAD(P)H dehydrogenase 1 (NQO1) OTZGGIVK NQO1_HUMAN Increases Expression [25]
26S proteasome regulatory subunit 6A (PSMC3) OTSKT0JI PRS6A_HUMAN Increases Expression [23]
Cyclic AMP-dependent transcription factor ATF-4 (ATF4) OTRFV19J ATF4_HUMAN Increases Expression [23]
Cyclic AMP-dependent transcription factor ATF-6 alpha (ATF6) OTAFHAVI ATF6A_HUMAN Increases Expression [7]
Retinoic acid receptor RXR-alpha (RXRA) OTP1TBDM RXRA_HUMAN Increases Expression [49]
Receptor tyrosine-protein kinase erbB-3 (ERBB3) OTRSST0A ERBB3_HUMAN Decreases Expression [35]
Ribosomal protein S6 kinase beta-1 (RPS6KB1) OTAELNGX KS6B1_HUMAN Decreases Phosphorylation [50]
G1/S-specific cyclin-D1 (CCND1) OT8HPTKJ CCND1_HUMAN Increases Expression [51]
Proteasome subunit alpha type-1 (PSMA1) OTNBVM2U PSA1_HUMAN Increases Expression [23]
Proteasome subunit alpha type-2 (PSMA2) OTJRT2ZL PSA2_HUMAN Increases Expression [23]
Proteasome subunit alpha type-3 (PSMA3) OT52M10V PSA3_HUMAN Increases Expression [23]
Proteasome subunit alpha type-4 (PSMA4) OTAD2XXI PSA4_HUMAN Increases Expression [23]
NF-kappa-B inhibitor alpha (NFKBIA) OTFT924M IKBA_HUMAN Increases Expression [52]
Aryl hydrocarbon receptor nuclear translocator (ARNT) OTMSIEZY ARNT_HUMAN Decreases Expression [53]
Calnexin (CANX) OTYP1F6J CALX_HUMAN Affects Localization [54]
Proteasome subunit beta type-9 (PSMB9) OTFV57T8 PSB9_HUMAN Increases Expression [23]
Proteasome subunit alpha type-5 (PSMA5) OT38E6Y1 PSA5_HUMAN Increases Expression [23]
Proteasome subunit beta type-4 (PSMB4) OTOJ9OHA PSB4_HUMAN Increases Expression [23]
Proteasome subunit beta type-6 (PSMB6) OT9VXPNW PSB6_HUMAN Increases Expression [23]
Proteasome subunit beta type-5 (PSMB5) OTOZXAS6 PSB5_HUMAN Decreases Expression [34]
Cystatin-D (CST5) OTHJXNJG CYTD_HUMAN Decreases Expression [23]
Retinoblastoma-like protein 1 (RBL1) OTDEBFYC RBL1_HUMAN Increases Expression [55]
Protein PML (PML) OT6SM2GD PML_HUMAN Decreases Degradation [56]
RAC-alpha serine/threonine-protein kinase (AKT1) OT8H2YY7 AKT1_HUMAN Increases Phosphorylation [26]
Catenin beta-1 (CTNNB1) OTZ932A3 CTNB1_HUMAN Decreases Degradation [57]
Polycomb complex protein BMI-1 (BMI1) OTROVLJ0 BMI1_HUMAN Increases Expression [58]
DNA damage-inducible transcript 3 protein (DDIT3) OTI8YKKE DDIT3_HUMAN Increases Expression [33]
Copper-transporting ATPase 2 (ATP7B) OTPWLNCO ATP7B_HUMAN Decreases Degradation [59]
Aryl hydrocarbon receptor (AHR) OTFE4EYE AHR_HUMAN Decreases Expression [53]
26S proteasome regulatory subunit 7 (PSMC2) OTJ4V337 PRS7_HUMAN Increases Expression [23]
Peroxisome proliferator-activated receptor gamma (PPARG) OTHMARHO PPARG_HUMAN Increases Activity [60]
Alpha-synuclein (SNCA) OTPWC1MR SYUA_HUMAN Increases Phosphorylation [58]
Proteasome subunit beta type-10 (PSMB10) OTURUR9B PSB10_HUMAN Decreases Expression [23]
Signal transducer and activator of transcription 6 (STAT6) OTCKMP49 STAT6_HUMAN Affects Phosphorylation [61]
Serine/threonine-protein kinase mTOR (MTOR) OTHH8KU7 MTOR_HUMAN Increases Expression [36]
Caspase-3 (CASP3) OTIJRBE7 CASP3_HUMAN Increases Cleavage [62]
26S proteasome regulatory subunit 6B (PSMC4) OTS3XN41 PRS6B_HUMAN Increases Expression [23]
Cyclin-dependent kinase inhibitor 1B (CDKN1B) OTNY5LLZ CDN1B_HUMAN Decreases Degradation [63]
Neurogenic locus notch homolog protein 1 (NOTCH1) OTI1WADQ NOTC1_HUMAN Increases Expression [64]
Glutamate--cysteine ligase catalytic subunit (GCLC) OTESDI4D GSH1_HUMAN Increases Expression [6]
Glutamate--cysteine ligase regulatory subunit (GCLM) OT6CP234 GSH0_HUMAN Increases Expression [25]
26S proteasome non-ATPase regulatory subunit 8 (PSMD8) OTY6X27P PSMD8_HUMAN Increases Expression [23]
CCAAT/enhancer-binding protein alpha (CEBPA) OTOM9OE4 CEBPA_HUMAN Increases Ubiquitination [65]
Proteasome subunit beta type-3 (PSMB3) OTVBON40 PSB3_HUMAN Increases Expression [23]
Proteasome subunit beta type-2 (PSMB2) OTX0UG5W PSB2_HUMAN Increases Expression [23]
Glycogen synthase kinase-3 beta (GSK3B) OTL3L14B GSK3B_HUMAN Decreases Expression [51]
Microsomal triglyceride transfer protein large subunit (MTTP) OTNUVSDT MTP_HUMAN Increases Expression [66]
Caspase-7 (CASP7) OTAPJ040 CASP7_HUMAN Increases Activity [32]
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN) OTOWDUNT PTEN_HUMAN Increases Expression [67]
Proteasome subunit alpha type-6 (PSMA6) OTJ6RPX5 PSA6_HUMAN Increases Expression [23]
26S proteasome regulatory subunit 4 (PSMC1) OTLHD56E PRS4_HUMAN Increases Expression [23]
26S proteasome regulatory subunit 8 (PSMC5) OTJOORMR PRS8_HUMAN Increases Expression [23]
26S proteasome regulatory subunit 10B (PSMC6) OTG8997V PRS10_HUMAN Increases Expression [23]
Glutathione S-transferase omega-1 (GSTO1) OTUJ93MN GSTO1_HUMAN Increases Expression [25]
Disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) OTTM6KRB ADA17_HUMAN Increases Expression [7]
Heat shock factor protein 1 (HSF1) OTYNJ4KP HSF1_HUMAN Increases Activity [40]
Protein SET (SET) OTGYYQJO SET_HUMAN Decreases Expression [31]
POU domain, class 5, transcription factor 1 (POU5F1) OTDHHN7O PO5F1_HUMAN Increases Expression [64]
Caveolin-1 (CAV1) OTEZUR1L CAV1_HUMAN Decreases Expression [68]
Heat shock factor protein 2 (HSF2) OTXNJIJ9 HSF2_HUMAN Increases Activity [40]
Transcription factor p65 (RELA) OTUJP9CN TF65_HUMAN Decreases Activity [43]
Sex-determining region Y protein (SRY) OT516T6D SRY_HUMAN Decreases Degradation [69]
Protein kinase C delta type (PRKCD) OTSEH90E KPCD_HUMAN Increases Phosphorylation [60]
Proteasome activator complex subunit 1 (PSME1) OTDHLJWH PSME1_HUMAN Decreases Expression [23]
Recombining binding protein suppressor of hairless (RBPJ) OTD7CUG0 SUH_HUMAN Increases Expression [70]
Bcl-2-like protein 1 (BCL2L1) OTRC5K9O B2CL1_HUMAN Decreases Expression [71]
Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1) OT2YYI1A MCL1_HUMAN Decreases Degradation [72]
Forkhead box protein M1 (FOXM1) OT5887KR FOXM1_HUMAN Decreases Expression [23]
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) OT4SO7J4 BNIP3_HUMAN Increases Expression [73]
TAR DNA-binding protein 43 (TARDBP) OTVOSFWW TADBP_HUMAN Increases Ubiquitination [74]
26S proteasome non-ATPase regulatory subunit 2 (PSMD2) OT6HZHN7 PSMD2_HUMAN Increases Expression [23]
Baculoviral IAP repeat-containing protein 3 (BIRC3) OT3E95KB BIRC3_HUMAN Increases Expression [26]
Phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1) OTXEE550 APR_HUMAN Increases Expression [23]
Transcription factor E2F2 (E2F2) OTO75RM7 E2F2_HUMAN Decreases Expression [23]
Reticulocalbin-2 (RCN2) OTIU8JWD RCN2_HUMAN Increases Expression [31]
Endoplasmic reticulum membrane sensor NFE2L1 (NFE2L1) OT1QHOS2 NF2L1_HUMAN Increases Expression [75]
Phosphatidate phosphatase LPIN1 (LPIN1) OTQ75KF2 LPIN1_HUMAN Increases Expression [76]
Proteasome activator complex subunit 4 (PSME4) OTDGF53O PSME4_HUMAN Increases Expression [23]
26S proteasome non-ATPase regulatory subunit 6 (PSMD6) OTX59EGK PSMD6_HUMAN Increases Expression [23]
Prostaglandin E synthase 3 (PTGES3) OTPPQWI0 TEBP_HUMAN Decreases Degradation [77]
ELAV-like protein 1 (ELAVL1) OTY55PLY ELAV1_HUMAN Increases Expression [78]
Nuclear factor erythroid 2-related factor 2 (NFE2L2) OT0HENJ5 NF2L2_HUMAN Increases Expression [6]
Bcl-2 homologous antagonist/killer (BAK1) OTDP6ILW BAK_HUMAN Increases Ubiquitination [79]
Hypoxia-inducible factor 1-alpha (HIF1A) OTADSC03 HIF1A_HUMAN Decreases Degradation [80]
Cytochrome P450 1B1 (CYP1B1) OTYXFLSD CP1B1_HUMAN Increases Stability [81]
Rab-like protein 6 (RABL6) OTJLVIQ1 RABL6_HUMAN Decreases Expression [23]
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) OTLS7C99 LRRK2_HUMAN Increases Ubiquitination [82]
E3 ubiquitin-protein ligase RNF144B (RNF144B) OTN7FCDE R144B_HUMAN Decreases Degradation [83]
FUN14 domain-containing protein 1 (FUNDC1) OTA6IVKQ FUND1_HUMAN Increases Expression [84]
Regulatory-associated protein of mTOR (RPTOR) OT4TQZ9F RPTOR_HUMAN Increases Expression [36]
COMM domain-containing protein 1 (COMMD1) OT7WUD5R COMD1_HUMAN Increases Expression [85]
Programmed cell death 6-interacting protein (PDCD6IP) OTS8T6A7 PDC6I_HUMAN Increases Expression [31]
Estrogen receptor beta (ESR2) OTXNR2WQ ESR2_HUMAN Increases Expression [86]
Histone deacetylase 2 (HDAC2) OTUYVFKN HDAC2_HUMAN Increases Ubiquitination [87]
Type II iodothyronine deiodinase (DIO2) OTGPNSLH IOD2_HUMAN Increases Expression [88]
Histone acetyltransferase KAT5 (KAT5) OTL7257A KAT5_HUMAN Increases Expression [89]
Tribbles homolog 3 (TRIB3) OTG5OS7X TRIB3_HUMAN Decreases Expression [23]
Proteasome subunit beta type-7 (PSMB7) OT2NKD2K PSB7_HUMAN Increases Expression [23]
26S proteasome non-ATPase regulatory subunit 1 (PSMD1) OTW258OV PSMD1_HUMAN Increases Expression [23]
Krueppel-like factor 6 (KLF6) OTQY9S7F KLF6_HUMAN Increases Expression [23]
Equilibrative nucleoside transporter 1 (SLC29A1) OTLOOZZS S29A1_HUMAN Increases Expression [23]
Endothelial PAS domain-containing protein 1 (EPAS1) OTRE3O8U EPAS1_HUMAN Increases Expression [90]
Angiotensin-converting enzyme 2 (ACE2) OTTRZGU7 ACE2_HUMAN Decreases Expression [7]
Microtubule-associated proteins 1A/1B light chain 3B (MAP1LC3B) OTUYHB84 MLP3B_HUMAN Increases Expression [91]
Gamma-aminobutyric acid receptor-associated protein-like 1 (GABARAPL1) OT4U7SBG GBRL1_HUMAN Increases Expression [23]
Glutathione S-transferase omega-2 (GSTO2) OTVDSNLH GSTO2_HUMAN Increases Expression [25]
Thiol S-methyltransferase TMT1A (TMT1A) OT4IAAZP TMT1A_HUMAN Decreases Expression [23]
Anillin (ANLN) OTXJY54C ANLN_HUMAN Decreases Expression [23]
Eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3) OT0DZGY4 E2AK3_HUMAN Increases Phosphorylation [7]
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) OTHCDQ22 PRGC1_HUMAN Decreases Degradation [92]
Proteasome activator complex subunit 2 (PSME2) OTYPP33T PSME2_HUMAN Decreases Expression [23]
26S proteasome non-ATPase regulatory subunit 13 (PSMD13) OTNQ351N PSD13_HUMAN Increases Expression [23]
E3 ubiquitin-protein ligase ARIH1 (ARIH1) OTO3XDR2 ARI1_HUMAN Increases Expression [93]
Solute carrier organic anion transporter family member 1B1 (SLCO1B1) OTNEN8QK SO1B1_HUMAN Decreases Degradation [94]
Parkinson disease protein 7 (PARK7) OT0SKNTG PARK7_HUMAN Decreases Response To Substance [95]
Polyamine-transporting ATPase 13A2 (ATP13A2) OTKWBUGK AT132_HUMAN Decreases Response To Substance [96]
------------------------------------------------------------------------------------
⏷ Show the Full List of 183 DOT(s)
Indication(s) of Idarubicin
Disease Entry ICD 11 Status REF
Acute myelogenous leukaemia 2A41 Approved [2]
Acute myeloid leukaemia 2A60 Approved [3]
Adult acute monocytic leukemia N.A. Approved [2]
Childhood acute megakaryoblastic leukemia N.A. Approved [2]
Leukemia N.A. Approved [2]
Idarubicin Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
DNA topoisomerase II (TOP2) TT0IHXV TOP2A_HUMAN; TOP2B_HUMAN Modulator [98]
------------------------------------------------------------------------------------
Idarubicin Interacts with 3 DTP Molecule(s)
DTP Name DTP ID UniProt ID Mode of Action REF
Multidrug resistance-associated protein 1 (ABCC1) DTSYQGK MRP1_HUMAN Substrate [99]
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [100]
Breast cancer resistance protein (ABCG2) DTI7UX6 ABCG2_HUMAN Substrate [100]
------------------------------------------------------------------------------------
Idarubicin Interacts with 2 DME Molecule(s)
DME Name DME ID UniProt ID Mode of Action REF
Cytochrome P450 2D6 (CYP2D6) DECB0K3 CP2D6_HUMAN Metabolism [101]
Cytochrome P450 2C9 (CYP2C9) DE5IED8 CP2C9_HUMAN Metabolism [101]
------------------------------------------------------------------------------------
Idarubicin Interacts with 9 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Estrogen receptor (ESR1) OTKLU61J ESR1_HUMAN Decreases Activity [97]
Heme oxygenase 1 (HMOX1) OTC1W6UX HMOX1_HUMAN Increases Expression [102]
Androgen receptor (AR) OTUBKAZZ ANDR_HUMAN Increases Activity [97]
Natriuretic peptides B (NPPB) OTSN2IPY ANFB_HUMAN Increases Expression [103]
Peroxisome proliferator-activated receptor gamma (PPARG) OTHMARHO PPARG_HUMAN Decreases Activity [97]
Caspase-3 (CASP3) OTIJRBE7 CASP3_HUMAN Increases Activity [104]
Peroxisome proliferator-activated receptor delta (PPARD) OTI4WTOP PPARD_HUMAN Decreases Activity [97]
Potassium voltage-gated channel subfamily H member 2 (KCNH2) OTZX881H KCNH2_HUMAN Decreases Activity [105]
Bile acid receptor (NR1H4) OTWZLPTB NR1H4_HUMAN Decreases Activity [97]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 DOT(s)

References

1 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
2 Idarubicin FDA Label
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7083).
4 A p38-p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells. Biochim Biophys Acta. 2008 Sep;1783(9):1613-22.
5 BACH1 is a specific repressor of HMOX1 that is inactivated by arsenite. J Biol Chem. 2008 Aug 15;283(33):22363-70.
6 Induction of ubiquitin C (UBC) gene transcription is mediated by HSF1: role of proteotoxic and oxidative stress. FEBS Open Bio. 2018 Jul 24;8(9):1471-1485. doi: 10.1002/2211-5463.12484. eCollection 2018 Sep.
7 The unfolded protein response controls ER stress-induced apoptosis of lung epithelial cells through angiotensin generation. Am J Physiol Lung Cell Mol Physiol. 2016 Nov 1;311(5):L846-L854. doi: 10.1152/ajplung.00449.2015. Epub 2016 Sep 16.
8 A novel UBA and UBX domain protein that binds polyubiquitin and VCP and is a substrate for SAPKs. Biochem J. 2004 Dec 1;384(Pt 2):391-400. doi: 10.1042/BJ20041498.
9 Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis. Int J Cancer. 2006 Apr 15;118(8):1892-900. doi: 10.1002/ijc.21580.
10 The proteasome inhibitor bortezomib is a potent inducer of zinc finger AN1-type domain 2a gene expression: role of heat shock factor 1 (HSF1)-heat shock factor 2 (HSF2) heterocomplexes. J Biol Chem. 2014 May 2;289(18):12705-15. doi: 10.1074/jbc.M113.513242. Epub 2014 Mar 11.
11 Ubiquilin1 represses migration and epithelial-to-mesenchymal transition of human non-small cell lung cancer cells. Oncogene. 2015 Mar 26;34(13):1709-17. doi: 10.1038/onc.2014.97. Epub 2014 Apr 21.
12 Increased ABCB1 expression in TP-110-resistant RPMI-8226 cells. Biosci Biotechnol Biochem. 2010;74(9):1913-9.
13 Regulation of human carbonyl reductase 3 (CBR3; SDR21C2) expression by Nrf2 in cultured cancer cells. Biochemistry. 2010 Oct 5;49(39):8499-511.
14 Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response elementDegradation of Nrf2 by the 26 S proteasome. J Biol Chem. 2003 Feb 14;278(7):4536-41.
15 Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II. J Steroid Biochem Mol Biol. 2005 Mar;94(4):337-46.
16 Selective induction of the tumor marker glutathione S-transferase P1 by proteasome inhibitors. J Biol Chem. 2005 Jul 1;280(26):25267-76.
17 Diallyl disulfide and diallyl trisulfide protect endothelial nitric oxide synthase against damage by oxidized low-density lipoprotein. Mol Nutr Food Res. 2010 May;54 Suppl 1:S42-52.
18 Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. Chem Biol Interact. 2011 May 30;191(1-3):239-49.
19 Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes. Biochem Pharmacol. 2012 May 1;83(9):1229-40.
20 Proteasomal interaction as a critical activity modulator of the human constitutive androstane receptor. Biochem J. 2014 Feb 15;458(1):95-107.
21 Histone deacetylase 4 promotes ubiquitin-dependent proteasomal degradation of Sp3 in SH-SY5Y cells treated with di(2-ethylhexyl)phthalate (DEHP), determining neuronal death. Toxicol Appl Pharmacol. 2014 Oct 1;280(1):190-8.
22 Novel mitochondrial substrates of omi indicate a new regulatory role in neurodegenerative disorders. PLoS One. 2009 Sep 18;4(9):e7100. doi: 10.1371/journal.pone.0007100.
23 Proteasome inhibition creates a chromatin landscape favorable to RNA Pol II processivity. J Biol Chem. 2020 Jan 31;295(5):1271-1287. doi: 10.1074/jbc.RA119.011174. Epub 2019 Dec 5.
24 Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells. Biochem J. 2013 Sep 1;454(2):283-93. doi: 10.1042/BJ20130481.
25 Differential effects of arsenic species on Nrf2 and Bach1 nuclear localization in cultured hepatocytes. Toxicol Appl Pharmacol. 2021 Feb 15;413:115404. doi: 10.1016/j.taap.2021.115404. Epub 2021 Jan 9.
26 Long-term incubation with proteasome inhibitors (PIs) induces IB degradation via the lysosomal pathway in an IB kinase (IKK)-dependent and IKK-independent manner. J Biol Chem. 2013 Nov 8;288(45):32777-32786. doi: 10.1074/jbc.M113.480921. Epub 2013 Oct 1.
27 Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells. Arch Toxicol. 2006 Jun;80(6):310-8. doi: 10.1007/s00204-005-0045-1. Epub 2005 Nov 19.
28 The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Cancer Res. 2007 May 15;67(10):4981-8. doi: 10.1158/0008-5472.CAN-06-4274.
29 Differential expression of PARK2 splice isoforms in an in vitro model of dopaminergic-like neurons exposed to toxic insults mimicking Parkinson's disease. J Cell Biochem. 2018 Jan;119(1):1062-1073. doi: 10.1002/jcb.26274. Epub 2017 Aug 23.
30 Cholesterol increases protein levels of the E3 ligase MARCH6 and thereby stimulates protein degradation. J Biol Chem. 2019 Feb 15;294(7):2436-2448. doi: 10.1074/jbc.RA118.005069. Epub 2018 Dec 13.
31 Proteomic signatures in thapsigargin-treated hepatoma cells. Chem Res Toxicol. 2011 Aug 15;24(8):1215-22. doi: 10.1021/tx200109y. Epub 2011 Jul 1.
32 Endoplasmic reticulum stress-mediated autophagy/apoptosis induced by capsaicin (8-methyl-N-vanillyl-6-nonenamide) and dihydrocapsaicin is regulated by the extent of c-Jun NH2-terminal kinase/extracellular signal-regulated kinase activation in WI38 lung epithelial fibroblast cells. J Pharmacol Exp Ther. 2009 Apr;329(1):112-22. doi: 10.1124/jpet.108.144113. Epub 2009 Jan 12.
33 Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Res. 2009 Feb 27;1257:16-24. doi: 10.1016/j.brainres.2008.11.104. Epub 2008 Dec 16.
34 The role of PSMB5 in sodium arsenite-induced oxidative stress in L-02 cells. Cell Stress Chaperones. 2020 May;25(3):533-540. doi: 10.1007/s12192-020-01104-1. Epub 2020 Apr 16.
35 Sulindac metabolites induce proteosomal and lysosomal degradation of the epidermal growth factor receptor. Cancer Prev Res (Phila). 2010 Apr;3(4):560-72. doi: 10.1158/1940-6207.CAPR-09-0159. Epub 2010 Mar 23.
36 Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation. J Biol Chem. 2015 May 29;290(22):14120-9. doi: 10.1074/jbc.M114.633057. Epub 2015 Apr 20.
37 Induction of steroid sulfatase expression in PC-3 human prostate cancer cells by insulin-like growth factor II. Toxicol Lett. 2013 Nov 25;223(2):109-15. doi: 10.1016/j.toxlet.2013.09.006. Epub 2013 Sep 18.
38 Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression. J Biol Chem. 2004 Jan 9;279(2):1323-9. doi: 10.1074/jbc.M307521200. Epub 2003 Oct 27.
39 Role of the proteasome in the regulation of fetal fibronectin secretion in human placenta. Ann N Y Acad Sci. 2001 Sep;943:340-51. doi: 10.1111/j.1749-6632.2001.tb03814.x.
40 Proteasome inhibitors induce heat shock response and increase IL-6 expression in human intestinal epithelial cells. Am J Physiol Regul Integr Comp Physiol. 2002 Apr;282(4):R1016-26. doi: 10.1152/ajpregu.00492.2001.
41 Estrogen responsiveness of IBEP-2, a new human cell line derived from breast carcinoma. Breast Cancer Res Treat. 2004 Jul;86(1):39-53. doi: 10.1023/B:BREA.0000032922.87541.31.
42 Tetracaine hydrochloride induces cell cycle arrest in melanoma by downregulating hnRNPA1. Toxicol Appl Pharmacol. 2022 Jan 1;434:115810. doi: 10.1016/j.taap.2021.115810. Epub 2021 Nov 23.
43 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins. Blood. 2005 Feb 15;105(4):1750-8. doi: 10.1182/blood-2004-04-1360. Epub 2004 Oct 21.
44 Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production. FEBS Lett. 2002 Aug 28;526(1-3):101-5. doi: 10.1016/s0014-5793(02)03151-4.
45 Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells. Mol Carcinog. 2011 Jan;50(1):24-35. doi: 10.1002/mc.20687.
46 Secretory defect and cytotoxicity: the potential disease mechanisms for the retinitis pigmentosa (RP)-associated interphotoreceptor retinoid-binding protein (IRBP). J Biol Chem. 2013 Apr 19;288(16):11395-406. doi: 10.1074/jbc.M112.418251. Epub 2013 Mar 13.
47 Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. Am J Physiol Cell Physiol. 2007 Jul;293(1):C477-85. doi: 10.1152/ajpcell.00075.2007. Epub 2007 Apr 18.
48 ERR contributes to HDAC6-induced chemoresistance of osteosarcoma cells. Cell Biol Toxicol. 2023 Jun;39(3):813-825. doi: 10.1007/s10565-021-09651-8. Epub 2021 Sep 15.
49 Arsenic decreases RXR-dependent transcription of CYP3A and suppresses immune regulators in hepatocytes. Int Immunopharmacol. 2012 Apr;12(4):651-6. doi: 10.1016/j.intimp.2012.01.008. Epub 2012 Feb 4.
50 The RNA polymerase III repressor MAF1 is regulated by ubiquitin-dependent proteasome degradation and modulates cancer drug resistance and apoptosis. J Biol Chem. 2019 Dec 13;294(50):19255-19268. doi: 10.1074/jbc.RA119.008849. Epub 2019 Oct 23.
51 Cell-specific regulation of Nrf2 during ROS-Dependent cell death caused by 2,3,5-tris(glutathion-S-yl)hydroquinone (TGHQ). Chem Biol Interact. 2019 Apr 1;302:1-10. doi: 10.1016/j.cbi.2019.01.027. Epub 2019 Jan 28.
52 Apoptosis induced by trimethyltin chloride in human neuroblastoma cells SY5Y is regulated by a balance and cross-talk between NF-B and MAPKs signaling pathways. Arch Toxicol. 2013 Jul;87(7):1273-85. doi: 10.1007/s00204-013-1021-9. Epub 2013 Feb 20.
53 Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells. Int Immunol. 2005 Jun;17(6):797-805. doi: 10.1093/intimm/dxh260. Epub 2005 May 17.
54 Absence of Bax switched MG132-induced apoptosis to non-apoptotic cell death that could be suppressed by transcriptional or translational inhibition. Apoptosis. 2007 Dec;12(12):2233-44. doi: 10.1007/s10495-007-0142-0.
55 Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells. Gastroenterology. 2010 May;138(5):1920-30. doi: 10.1053/j.gastro.2010.01.007. Epub 2010 Jan 25.
56 Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML. Toxicol Appl Pharmacol. 2015 Sep 15;287(3):191-201. doi: 10.1016/j.taap.2015.05.018. Epub 2015 Jun 3.
57 Estrogen and ER enhanced -catenin degradation and suppressed its downstream target genes to block the metastatic function of HA22T hepatocellular carcinoma cells via modulating GSK-3 and -TrCP expression. Environ Toxicol. 2017 Feb;32(2):519-529. doi: 10.1002/tox.22256. Epub 2016 Mar 18.
58 Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of -synuclein in experimental Parkinson's disease models. Neuropharmacology. 2021 Aug 15;194:108372. doi: 10.1016/j.neuropharm.2020.108372. Epub 2020 Nov 4.
59 Involvement of protein kinase D in expression and trafficking of ATP7B (copper ATPase). J Biol Chem. 2011 Mar 4;286(9):7389-96. doi: 10.1074/jbc.M110.171454. Epub 2010 Dec 27.
60 Proteasome inhibitors induce peroxisome proliferator-activated receptor transactivation through RXR accumulation and a protein kinase C-dependent pathway. Exp Cell Res. 2005 Mar 10;304(1):234-43. doi: 10.1016/j.yexcr.2004.11.004. Epub 2004 Dec 10.
61 Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor alpha, the tyrosine phosphatase SHP-1, and the proteasome. J Biol Chem. 2003 Feb 7;278(6):3903-11. doi: 10.1074/jbc.M211747200. Epub 2002 Nov 28.
62 Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway. Mol Cancer Ther. 2008 Sep;7(9):2866-75. doi: 10.1158/1535-7163.MCT-08-0391.
63 Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium. Cancer Res. 2007 Feb 1;67(3):1007-18. doi: 10.1158/0008-5472.CAN-06-0235.
64 Cobalt and nickel stabilize stem cell transcription factor OCT4 through modulating its sumoylation and ubiquitination. PLoS One. 2014 Jan 31;9(1):e86620. doi: 10.1371/journal.pone.0086620. eCollection 2014.
65 Protein kinase Cdelta stimulates proteasome-dependent degradation of C/EBPalpha during apoptosis induction of leukemic cells. PLoS One. 2009 Aug 7;4(8):e6552. doi: 10.1371/journal.pone.0006552.
66 Cadmium induces triglyceride levels via microsomal triglyceride transfer protein (MTTP) accumulation caused by lysosomal deacidification regulated by endoplasmic reticulum (ER) Ca(2+) homeostasis. Chem Biol Interact. 2021 Oct 1;348:109649. doi: 10.1016/j.cbi.2021.109649. Epub 2021 Sep 10.
67 Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities. Int J Mol Sci. 2020 Nov 26;21(23):8982. doi: 10.3390/ijms21238982.
68 Nitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1. J Biol Chem. 2009 Oct 9;284(41):28476-28484. doi: 10.1074/jbc.M109.050864. Epub 2009 Aug 25.
69 Human Sex Determination at the Edge of Ambiguity: INHERITED XY SEX REVERSAL DUE TO ENHANCED UBIQUITINATION AND PROTEASOMAL DEGRADATION OF A MASTER TRANSCRIPTION FACTOR. J Biol Chem. 2016 Oct 14;291(42):22173-22195. doi: 10.1074/jbc.M116.741959. Epub 2016 Aug 30.
70 Presenilin-2 regulates the degradation of RBP-Jk protein through p38 mitogen-activated protein kinase. J Cell Sci. 2012 Mar 1;125(Pt 5):1296-308. doi: 10.1242/jcs.095984. Epub 2012 Feb 2.
71 NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line. Am J Hematol. 2006 Dec;81(12):938-45. doi: 10.1002/ajh.20732.
72 An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs. Oncogene. 2010 Dec 9;29(49):6428-41. doi: 10.1038/onc.2010.380. Epub 2010 Aug 30.
73 Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine. Eur J Cancer. 2014 Dec;50(18):3243-61. doi: 10.1016/j.ejca.2014.09.012. Epub 2014 Oct 13.
74 Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules. J Biol Chem. 2020 Jan 17;295(3):673-689. doi: 10.1074/jbc.RA119.010617. Epub 2019 Nov 28.
75 Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells. Toxicol Appl Pharmacol. 2021 Jun 1;420:115523. doi: 10.1016/j.taap.2021.115523. Epub 2021 Apr 8.
76 The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF- Signaling in Hepatic Stellate Cells. Toxicol Sci. 2016 Sep;153(1):28-38. doi: 10.1093/toxsci/kfw109. Epub 2016 Jun 26.
77 Tosylcyclonovobiocic acids promote cleavage of the hsp90-associated cochaperone p23. Biochem Biophys Res Commun. 2009 Feb 6;379(2):514-8. doi: 10.1016/j.bbrc.2008.12.102. Epub 2008 Dec 30.
78 Autophagy activation clears ELAVL1/HuR-mediated accumulation of SQSTM1/p62 during proteasomal inhibition in human retinal pigment epithelial cells. PLoS One. 2013 Jul 29;8(7):e69563. doi: 10.1371/journal.pone.0069563. Print 2013.
79 Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies. Clin Cancer Res. 2023 Jan 17;29(2):446-457. doi: 10.1158/1078-0432.CCR-22-2088.
80 Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha. Int J Cancer. 2008 Jan 1;122(1):5-14. doi: 10.1002/ijc.23075.
81 Proteasomal degradation of human CYP1B1: effect of the Asn453Ser polymorphism on the post-translational regulation of CYP1B1 expression. Mol Pharmacol. 2005 Feb;67(2):435-43. doi: 10.1124/mol.104.006056. Epub 2004 Oct 14.
82 Arsenite stress down-regulates phosphorylation and 14-3-3 binding of leucine-rich repeat kinase 2 (LRRK2), promoting self-association and cellular redistribution. J Biol Chem. 2014 Aug 1;289(31):21386-400. doi: 10.1074/jbc.M113.528463. Epub 2014 Jun 18.
83 Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation. Cell Death Dis. 2018 May 1;9(5):504. doi: 10.1038/s41419-018-0521-1.
84 FUNDC1 regulates receptor-mediated mitophagy independently of the PINK1/Parkin-dependent pathway in rotenone-treated SH-SY5Y cells. Food Chem Toxicol. 2020 Mar;137:111163. doi: 10.1016/j.fct.2020.111163. Epub 2020 Jan 27.
85 The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells. J Amino Acids. 2013;2013:251398. doi: 10.1155/2013/251398. Epub 2013 Jan 16.
86 Involvement of suppressor for Gal 1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors. J Biol Chem. 2004 Mar 26;279(13):12020-6. doi: 10.1074/jbc.M312762200. Epub 2003 Dec 30.
87 Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol. 2008 Sep;39(3):312-23. doi: 10.1165/rcmb.2008-0012OC. Epub 2008 Apr 17.
88 Disruption of type 2 iodothyronine deiodinase activity in cultured human glial cells by polybrominated diphenyl ethers. Chem Res Toxicol. 2015 Jun 15;28(6):1265-74. doi: 10.1021/acs.chemrestox.5b00072. Epub 2015 Jun 2.
89 Arsenite Binds to the Zinc Finger Motif of TIP60 Histone Acetyltransferase and Induces Its Degradation via the 26S Proteasome. Chem Res Toxicol. 2017 Sep 18;30(9):1685-1693. doi: 10.1021/acs.chemrestox.7b00146. Epub 2017 Sep 7.
90 Vulnerability of HIF1 and HIF2 to damage by proteotoxic stressors. Toxicol Appl Pharmacol. 2022 Jun 15;445:116041. doi: 10.1016/j.taap.2022.116041. Epub 2022 Apr 30.
91 Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways. Mol Neurobiol. 2016 Oct;53(8):5229-51. doi: 10.1007/s12035-015-9414-9. Epub 2015 Sep 26.
92 Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor co-activator-1 protein. Br J Pharmacol. 2010 Oct;161(4):771-81. doi: 10.1111/j.1476-5381.2010.00900.x.
93 The E3 ubiquitin ligase ARIH1 protects against genotoxic stress by initiating a 4EHP-mediated mRNA translation arrest. Mol Cell Biol. 2015 Apr;35(7):1254-68. doi: 10.1128/MCB.01152-14. Epub 2015 Jan 26.
94 Amino-terminal region of human organic anion transporting polypeptide 1B1 dictates transporter stability and substrate interaction. Toxicol Appl Pharmacol. 2019 Sep 1;378:114642. doi: 10.1016/j.taap.2019.114642. Epub 2019 Jun 27.
95 Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease. J Neurochem. 2008 Jun 1;105(6):2435-53. doi: 10.1111/j.1471-4159.2008.05333.x.
96 Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants. J Neurosci Res. 2012 Dec;90(12):2306-16. doi: 10.1002/jnr.23112. Epub 2012 Jul 30.
97 Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor. Sci Rep. 2014 Sep 26;4:6437. doi: 10.1038/srep06437.
98 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
99 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
100 Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia. Leukemia. 2008 Nov;22(11):2110-5.
101 In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin. Hematology. 2004 Jun;9(3):217-21.
102 A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro. J Am Soc Nephrol. 2016 Apr;27(4):1015-28. doi: 10.1681/ASN.2015010060. Epub 2015 Aug 10.
103 The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia. Neoplasma. 2005;52(5):430-4.
104 The induction of apoptosis by daunorubicin and idarubicin in human trisomic and diabetic fibroblasts. Cell Mol Biol Lett. 2008;13(2):182-94. doi: 10.2478/s11658-007-0045-7. Epub 2008 Apr 10.
105 Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. Toxicol Sci. 2013 Dec;136(2):581-94. doi: 10.1093/toxsci/kft205. Epub 2013 Sep 19.